LDTs
Public health labs have handled most testing thus far for the Texas and New Mexico outbreaks, but commercial labs are beginning to bring molecular measles assays online.
Top Five Articles on 360Dx Last Week: Pfizer Shutting Down Lucira Health Business; More
Last week, readers were most interested in a story about Pfizer shuttering the Lucira Health business that it acquired in 2023.
College of American Pathologists Calls on HHS to End FDA Oversight of LDTs
CAP suggested in a letter to HHS that FDA regulation of LDTs conflicts with President Donald Trump's Jan. 31 executive order instructing agencies to reduce regulations.
The firm is developing prognostic cancer tests targeting "master driver" genes that control cancer-related biological pathways.
Top Five Articles on 360Dx Last Week: Sepsis Testing in 2024; Clinical Labs and FDA LDT Rule; More
Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.